Bias due to false-positive diagnoses in an automated health insurance claims database

Drug Safety

Volumn 29, Issue 11, 2006, Pages 1069-1075

  Lanes, Stephan F ^a   De Luise, Cynthia ^b  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA BASE; DEATH CERTIFICATE; DISEASE REGISTRY; DRUG SAFETY; FALSE POSITIVE RESULT; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

BIAS (EPIDEMIOLOGY); BRONCHODILATOR AGENTS; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FALSE POSITIVE REACTIONS; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REPORTING; INSURANCE, HEALTH; MEDICAL RECORD LINKAGE; NORTH AMERICA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES;

EID: 33845503881     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200629110-00006     Document Type: Article

References (18)

1. Harris G. Drug safety system is broken, a top FDA official says. New York Times 2005 Jun 9; Late Edition-Final, Sect. A: 24 (col 4)
2. Fuhrmans V. Early-warning tool for unsafe drugs. Wall Street Journal 2005 Apr 28, D4
3. Downey W, Stang MR, Beck P, et al. Health services databases in Saskatchewan. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. New York (NY): John Wiley & Sons Ltd, 2005: 295-310
4. Selby JV, Smith DH, Johnson ES, et al. Kaiser permanente medical care program. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. New York (NY): John Wiley & Sons Ltd, 2005: 241-60
5. Shatin D, Rawson NSB, Stergachis A. UnitedHealth Group. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. New York (NY): John Wiley & Sons Ltd, 2005: 271-80
6. Lanza L, Norman H, Quinn SG, et al. A cohort study of cardiovascular conditions in COPD. Auburndale (MA): Ingenix Epidemiology, a UnitedHealth Group Company, 2003 Jul 29 (data on file)
7. de Luise C, Lanes S, Curkendall S, et al. Cardiovascular morbidity and mortality among persons with chronic obstructive pulmonary disease [abstract]. Pharmacoepidemiol Drug Saf 2004; 13: S238
8. Sidney S, Sorel M, Quesenberry CP, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-75
9. Curkendall S, de Luise C, Jones J, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease. Saskatchewan, Canada. Ann Epidemiol 2006; 16: 63-70
10. National Hospital Discharge Survey [online]. Available from URL: http://www.cdc.gov/nchs/data/ad/ad319.pdf [Accessed 2005 Jul 7]
11. Quam L, Ellis LBM, Venus P, et al. Using claims data for epidemiologic research: the concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Med Care 1993; 131: 498-507
12. Lanza L, Dreyer NA, Schultz NJ, et al. Use of insurance claims in epidemiologic research: identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis and renal disease. Pharmacoepidemiol Drug Saf 1995; 4: 239-48
13. Sands BE, Duh MS, Cali C, et al. Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation. Pharmacoepidemiol Drug Saf 2006; 15: 47-56
14. Psaty BM, Boineau R, Kuller LH, et al. The potential costs of upcoding for heart failure in the United States. Am J Cardiol 1999; 84: 108-9
15. Silverman E, Skinner J. Medicare upcoding and hospital ownership. J Health Econ 2004; 23 (2): 369-89
16. West SL, Strom BL, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. New York (NY): John Wiley & Sons Ltd, 2005: 709-66
17. Rancourt J. UnitedHealth's i3 unit tapped by FDA to provide postmarketing surveillance. FDC Reports, Inc. The Pink Sheet Daily 2005 Sep 28. No. 6
18. Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1998: 130-4